{
  "success": true,
  "pagesUsed": [
    1,
    10,
    14
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "SIGNATURES",
        "text": "SIGNATURES",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "I",
        "sectionTitle": "SIGNATURES",
        "sectionType": {
          "id": "d1c5654e-edf6-4f23-ab5b-3ac1a0025793",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "CONTACT DETAILS OF KEY SPONSOR’S PERSONNEL",
        "text": "CONTACT DETAILS OF KEY SPONSOR’S PERSONNEL",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "II",
        "sectionTitle": "CONTACT DETAILS OF KEY SPONSOR’S PERSONNEL",
        "sectionType": {
          "id": "fe9a38c8-ad4c-4ebd-9ae6-1da81d5634d2",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "LIST OF ABBREVIATIONS AND DEFINITION OF KEY TERMS",
        "text": "LIST OF ABBREVIATIONS AND DEFINITION OF KEY TERMS",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "III",
        "sectionTitle": "LIST OF ABBREVIATIONS AND DEFINITION OF KEY TERMS",
        "sectionType": {
          "id": "be6e435c-37e6-4a1d-9d13-57958c13f1de",
          "code": "Other",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Other",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "SYNOPSIS",
        "text": "SYNOPSIS",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "IV",
        "sectionTitle": "SYNOPSIS",
        "sectionType": {
          "id": "12264e7e-6d6e-495e-bff5-316bb9fb928f",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_5",
        "name": "FLOW CHART AND SCHEDULE OF ASSESSMENTS",
        "text": "FLOW CHART AND SCHEDULE OF ASSESSMENTS",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "V",
        "sectionTitle": "FLOW CHART AND SCHEDULE OF ASSESSMENTS",
        "sectionType": {
          "id": "16751399-507a-4156-90e3-5ce578f131a7",
          "code": "Assessments",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Assessments",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_6",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "76c69f0a-6d88-469b-b948-01534ba902ee",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_6_1",
          "nci_6_2",
          "nci_6_3",
          "nci_6_4",
          "nci_6_5",
          "nci_6_6"
        ]
      },
      {
        "id": "nc_7",
        "name": "STUDY OBJECTIVE(S), DESIGN AND ENDPOINTS",
        "text": "STUDY OBJECTIVE(S), DESIGN AND ENDPOINTS",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "STUDY OBJECTIVE(S), DESIGN AND ENDPOINTS",
        "sectionType": {
          "id": "2ed83f98-f5df-49a7-b13d-ccd0a640c06b",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_7_1",
          "nci_7_2",
          "nci_7_3",
          "nci_7_4",
          "nci_7_5",
          "nci_7_6",
          "nci_7_7",
          "nci_7_8",
          "nci_7_9",
          "nci_7_10",
          "nci_7_11",
          "nci_7_12",
          "nci_7_13"
        ]
      },
      {
        "id": "nc_8",
        "name": "STUDY POPULATION",
        "text": "STUDY POPULATION",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY POPULATION",
        "sectionType": {
          "id": "ece6dd8c-3de3-40b6-9ba0-51dc11234c24",
          "code": "Study Population",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Population",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2",
          "nci_8_3"
        ]
      },
      {
        "id": "nc_9",
        "name": "TREATMENT(S)",
        "text": "TREATMENT(S)",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "TREATMENT(S)",
        "sectionType": {
          "id": "60be9a00-e08a-48af-86b8-54919c145886",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        }
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_6_1",
        "name": "Background",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Background"
      },
      {
        "id": "nci_6_2",
        "name": "Nonclinical and Clinical Data",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Nonclinical and Clinical Data"
      },
      {
        "id": "nci_6_3",
        "name": "Nonclinical Data",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2.1",
        "sectionTitle": "Nonclinical Data"
      },
      {
        "id": "nci_6_4",
        "name": "Clinical Data",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2.2",
        "sectionTitle": "Clinical Data"
      },
      {
        "id": "nci_6_5",
        "name": "Summary of Key Safety Information for Study Drugs",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Summary of Key Safety Information for Study Drugs"
      },
      {
        "id": "nci_6_6",
        "name": "Risk-Benefit Assessment",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.4",
        "sectionTitle": "Risk-Benefit Assessment"
      },
      {
        "id": "nci_7_1",
        "name": "Study Objectives",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1",
        "sectionTitle": "Study Objectives"
      },
      {
        "id": "nci_7_2",
        "name": "Primary Objective",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1.1",
        "sectionTitle": "Primary Objective"
      },
      {
        "id": "nci_7_3",
        "name": "Secondary Objectives",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1.2",
        "sectionTitle": "Secondary Objectives"
      },
      {
        "id": "nci_7_4",
        "name": "Safety Objective",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1.3",
        "sectionTitle": "Safety Objective"
      },
      {
        "id": "nci_7_5",
        "name": "Exploratory Objective (North America sites only)",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.1.4",
        "sectionTitle": "Exploratory Objective (North America sites only)"
      },
      {
        "id": "nci_7_6",
        "name": "Study Design and Dose Rationale",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2",
        "sectionTitle": "Study Design and Dose Rationale"
      },
      {
        "id": "nci_7_7",
        "name": "Study Design",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2.1",
        "sectionTitle": "Study Design"
      },
      {
        "id": "nci_7_8",
        "name": "Dose Rationale",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.2.2",
        "sectionTitle": "Dose Rationale"
      },
      {
        "id": "nci_7_9",
        "name": "Endpoints",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3",
        "sectionTitle": "Endpoints"
      },
      {
        "id": "nci_7_10",
        "name": "Primary Endpoints",
        "text": "",
        "order": 9,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3.1",
        "sectionTitle": "Primary Endpoints"
      },
      {
        "id": "nci_7_11",
        "name": "Secondary Endpoints",
        "text": "",
        "order": 10,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3.2",
        "sectionTitle": "Secondary Endpoints"
      },
      {
        "id": "nci_7_12",
        "name": "Safety Endpoints",
        "text": "",
        "order": 11,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3.3",
        "sectionTitle": "Safety Endpoints"
      },
      {
        "id": "nci_7_13",
        "name": "Exploratory Endpoint (North America sites only)",
        "text": "",
        "order": 12,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "2.3.4",
        "sectionTitle": "Exploratory Endpoint (North America sites only)"
      },
      {
        "id": "nci_8_1",
        "name": "Selection of Study Population",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.1",
        "sectionTitle": "Selection of Study Population"
      },
      {
        "id": "nci_8_2",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.2",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_8_3",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "3.3",
        "sectionTitle": "Exclusion Criteria"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "ADT",
        "expandedText": "Androgen deprivation therapy",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "AE",
        "expandedText": "Adverse event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "AESI",
        "expandedText": "Adverse events of special interest",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "ALT",
        "expandedText": "Alanine aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "APEBV",
        "expandedText": "Astellas Pharma Europe B.V.",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "APGD",
        "expandedText": "Astellas Pharma Global Development, Inc",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "AR",
        "expandedText": "Androgen receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "AST",
        "expandedText": "Aspartate aminotransferase",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "AUST",
        "expandedText": "Astellas United States Technologies, Inc",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "BHA",
        "expandedText": "Butylated hydroxyanisole",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "BHT",
        "expandedText": "Butylated hydroxytoluene",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "BPI-SF",
        "expandedText": "Brief Pain Inventory-Short Form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "CIOMS",
        "expandedText": "Council for International Organizations of Medical Sciences",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "CLCR",
        "expandedText": "Creatinine clearance",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "CRF",
        "expandedText": "Case report form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "CRPC",
        "expandedText": "Castration-resistant prostate cancer",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "CT",
        "expandedText": "Computed tomography",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "CTCAE",
        "expandedText": "Common Terminology Criteria for Adverse Events",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "CYP",
        "expandedText": "Cytochrome P450",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "DSMB",
        "expandedText": "Data Safety Monitoring Board",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "ECG",
        "expandedText": "Electrocardiogram",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "ECOG",
        "expandedText": "Eastern Cooperative Oncology Group",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "eCRF",
        "expandedText": "Electronic case report form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "EDC",
        "expandedText": "Electronic data capture",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "EGFR",
        "expandedText": "Epidermal growth factor receptor",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "EQ-5D-5L",
        "expandedText": "EuroQol Group-5 Dimension-5 Level Instrument",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "FACT-P",
        "expandedText": "Functional Assessment of Cancer Therapy-Prostate",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "GABA",
        "expandedText": "γ-aminobutyric acid",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "GCP",
        "expandedText": "Good Clinical Practice",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "GMP",
        "expandedText": "Good Manufacturing Practice",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "HDPE",
        "expandedText": "High-density polyethylene",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "HR",
        "expandedText": "Hazard ratio",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_33",
        "abbreviatedText": "ICF",
        "expandedText": "Informed consent form",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_34",
        "abbreviatedText": "ICH",
        "expandedText": "International Council on Harmonisation",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_35",
        "abbreviatedText": "mHSPC",
        "expandedText": "metastatic Hormone Sensitive Prostate Cancer",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_36",
        "abbreviatedText": "rPFS",
        "expandedText": "radiographic progression-free survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_37",
        "abbreviatedText": "OS",
        "expandedText": "overall survival",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_38",
        "abbreviatedText": "SSE",
        "expandedText": "Symptomatic Skeletal Event",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_39",
        "abbreviatedText": "QoL",
        "expandedText": "Quality of Life",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_40",
        "abbreviatedText": "QLQ-PR25",
        "expandedText": "Quality of Life Prostate-specific Questionnaire",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_41",
        "abbreviatedText": "PSA",
        "expandedText": "prostate-specific antigen",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_42",
        "abbreviatedText": "ORR",
        "expandedText": "objective response rate",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 9,
      "itemCount": 22,
      "abbreviationCount": 42
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "ARCHES: A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "5.1",
      "versionDate": "18 Apr 2022",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "ADT",
          "expansion": "Androgen deprivation therapy"
        },
        {
          "abbreviation": "AE",
          "expansion": "Adverse event"
        },
        {
          "abbreviation": "AESI",
          "expansion": "Adverse events of special interest"
        },
        {
          "abbreviation": "ALT",
          "expansion": "Alanine aminotransferase"
        },
        {
          "abbreviation": "APEBV",
          "expansion": "Astellas Pharma Europe B.V."
        },
        {
          "abbreviation": "APGD",
          "expansion": "Astellas Pharma Global Development, Inc"
        },
        {
          "abbreviation": "AR",
          "expansion": "Androgen receptor"
        },
        {
          "abbreviation": "AST",
          "expansion": "Aspartate aminotransferase"
        },
        {
          "abbreviation": "AUST",
          "expansion": "Astellas United States Technologies, Inc"
        },
        {
          "abbreviation": "BHA",
          "expansion": "Butylated hydroxyanisole"
        },
        {
          "abbreviation": "BHT",
          "expansion": "Butylated hydroxytoluene"
        },
        {
          "abbreviation": "BPI-SF",
          "expansion": "Brief Pain Inventory-Short Form"
        },
        {
          "abbreviation": "CIOMS",
          "expansion": "Council for International Organizations of Medical Sciences"
        },
        {
          "abbreviation": "CLCR",
          "expansion": "Creatinine clearance"
        },
        {
          "abbreviation": "CRF",
          "expansion": "Case report form"
        },
        {
          "abbreviation": "CRPC",
          "expansion": "Castration-resistant prostate cancer"
        },
        {
          "abbreviation": "CT",
          "expansion": "Computed tomography"
        },
        {
          "abbreviation": "CTCAE",
          "expansion": "Common Terminology Criteria for Adverse Events"
        },
        {
          "abbreviation": "CYP",
          "expansion": "Cytochrome P450"
        },
        {
          "abbreviation": "DSMB",
          "expansion": "Data Safety Monitoring Board"
        },
        {
          "abbreviation": "ECG",
          "expansion": "Electrocardiogram"
        },
        {
          "abbreviation": "ECOG",
          "expansion": "Eastern Cooperative Oncology Group"
        },
        {
          "abbreviation": "eCRF",
          "expansion": "Electronic case report form"
        },
        {
          "abbreviation": "EDC",
          "expansion": "Electronic data capture"
        },
        {
          "abbreviation": "EGFR",
          "expansion": "Epidermal growth factor receptor"
        },
        {
          "abbreviation": "EQ-5D-5L",
          "expansion": "EuroQol Group-5 Dimension-5 Level Instrument"
        },
        {
          "abbreviation": "FACT-P",
          "expansion": "Functional Assessment of Cancer Therapy-Prostate"
        },
        {
          "abbreviation": "GABA",
          "expansion": "γ-aminobutyric acid"
        },
        {
          "abbreviation": "GCP",
          "expansion": "Good Clinical Practice"
        },
        {
          "abbreviation": "GMP",
          "expansion": "Good Manufacturing Practice"
        },
        {
          "abbreviation": "HDPE",
          "expansion": "High-density polyethylene"
        },
        {
          "abbreviation": "HR",
          "expansion": "Hazard ratio"
        },
        {
          "abbreviation": "ICF",
          "expansion": "Informed consent form"
        },
        {
          "abbreviation": "ICH",
          "expansion": "International Council on Harmonisation"
        },
        {
          "abbreviation": "mHSPC",
          "expansion": "metastatic Hormone Sensitive Prostate Cancer"
        },
        {
          "abbreviation": "rPFS",
          "expansion": "radiographic progression-free survival"
        },
        {
          "abbreviation": "OS",
          "expansion": "overall survival"
        },
        {
          "abbreviation": "SSE",
          "expansion": "Symptomatic Skeletal Event"
        },
        {
          "abbreviation": "QoL",
          "expansion": "Quality of Life"
        },
        {
          "abbreviation": "QLQ-PR25",
          "expansion": "Quality of Life Prostate-specific Questionnaire"
        },
        {
          "abbreviation": "PSA",
          "expansion": "prostate-specific antigen"
        },
        {
          "abbreviation": "ORR",
          "expansion": "objective response rate"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "ARCHES: A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC)",
        "version": "5.1",
        "versionDate": "18 Apr 2022"
      },
      "sections": [
        {
          "number": "I",
          "title": "SIGNATURES",
          "type": "Other"
        },
        {
          "number": "II",
          "title": "CONTACT DETAILS OF KEY SPONSOR’S PERSONNEL",
          "type": "Other"
        },
        {
          "number": "III",
          "title": "LIST OF ABBREVIATIONS AND DEFINITION OF KEY TERMS",
          "type": "Other"
        },
        {
          "number": "IV",
          "title": "SYNOPSIS",
          "type": "Synopsis"
        },
        {
          "number": "V",
          "title": "FLOW CHART AND SCHEDULE OF ASSESSMENTS",
          "type": "Assessments"
        },
        {
          "number": "1",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Background"
            },
            {
              "number": "1.2",
              "title": "Nonclinical and Clinical Data"
            },
            {
              "number": "1.2.1",
              "title": "Nonclinical Data"
            },
            {
              "number": "1.2.2",
              "title": "Clinical Data"
            },
            {
              "number": "1.3",
              "title": "Summary of Key Safety Information for Study Drugs"
            },
            {
              "number": "1.4",
              "title": "Risk-Benefit Assessment"
            }
          ]
        },
        {
          "number": "2",
          "title": "STUDY OBJECTIVE(S), DESIGN AND ENDPOINTS",
          "type": "Objectives",
          "subsections": [
            {
              "number": "2.1",
              "title": "Study Objectives"
            },
            {
              "number": "2.1.1",
              "title": "Primary Objective"
            },
            {
              "number": "2.1.2",
              "title": "Secondary Objectives"
            },
            {
              "number": "2.1.3",
              "title": "Safety Objective"
            },
            {
              "number": "2.1.4",
              "title": "Exploratory Objective (North America sites only)"
            },
            {
              "number": "2.2",
              "title": "Study Design and Dose Rationale"
            },
            {
              "number": "2.2.1",
              "title": "Study Design"
            },
            {
              "number": "2.2.2",
              "title": "Dose Rationale"
            },
            {
              "number": "2.3",
              "title": "Endpoints"
            },
            {
              "number": "2.3.1",
              "title": "Primary Endpoints"
            },
            {
              "number": "2.3.2",
              "title": "Secondary Endpoints"
            },
            {
              "number": "2.3.3",
              "title": "Safety Endpoints"
            },
            {
              "number": "2.3.4",
              "title": "Exploratory Endpoint (North America sites only)"
            }
          ]
        },
        {
          "number": "3",
          "title": "STUDY POPULATION",
          "type": "Study Population",
          "subsections": [
            {
              "number": "3.1",
              "title": "Selection of Study Population"
            },
            {
              "number": "3.2",
              "title": "Inclusion Criteria"
            },
            {
              "number": "3.3",
              "title": "Exclusion Criteria"
            }
          ]
        },
        {
          "number": "4",
          "title": "TREATMENT(S)",
          "type": "Treatment"
        }
      ]
    }
  }
}